retatrutide 2 months Tirzepatide vs. Retatrutide: Key Differences Explained Retatrutide Results: How Long Before

The Safety Profile Adverse events tracked the familiar GLP-1-class pattern, scaled up by dose

Procedures such as gastric bypass or sleeve gastrectomy produce substantial, sustained weight loss and often induce diabetes remission

The titration regimen described in the NEJM 2023 obesity trial (Jastreboff et al.) progressed as follows: Weeks 14 : 2 mg once weekly Weeks 58 : 4 mg once weekly Weeks 912 : 8 mg once weekly Week 12 onwards : Up to 12 mg once weekly (in higher-dose cohorts) This regimen was used exclusively within a regulated clinical trial setting and does not constitute an approved dosing schedule

Saxenda (liraglutide) : Earlier-generation GLP-1 medication showing approximately 8% weight loss over 56 weeks in clinical trials

Monitoring kidney function and discussing potential risks and benefits with a healthcare provider is essential